Market Overview

Syneron Settles US Patent Infringement Suit with EndyMed, Eclipse Aesthetics

Share:
Related ELOS
Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser
Syneron Medical Reports Study Published in May's JDS Showed 'Significant Improvement' in Face, Neck Treatment Results

Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company announced today, jointly with EndyMed Medical Ltd. and Eclipse Aesthetics, that Syneron has dismissed its United States patent infringement lawsuit against EndyMed and Eclipse Aesthetics relating to EndyMed's Fractional Skin Resurfacing Products. EndyMed and its United States distributor, Eclipse Aesthetics, agreed to immediately stop selling EndyMed's Fractional Skin Resurfacing Products in the United States but may continue to service and support previously purchased products and supply replacement electrodes for them.

Posted-In: News Legal

 

Related Articles (ELOS)

Get Benzinga's Newsletters